// App-Quantinova.ai

: NASH vs. Non-NASH HCC within and Beyond Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma

Researchers

Presenter

  • L. Rajendran

Principal Investigators

  • F. Murillo Perez

  • T. Ivanics

  • M. Claasen

  • B. Hansen

  • D. Wallace

  • P. Yoon

  • G. Sapisochin

Medical Centers

  • Westmead Hospital, Department of Surgery, Sydney, Australia

  • University of Toronto, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada

  • Erasmus University Medical Centre, Department of Surgery, Rotterdam, Netherlands

  • Toronto Centre for Liver Disease, University Health Network, Toronto, ON, Canada

  • Akademiska Sjukhuset, Uppsala University, Department of Surgical Sciences, Uppsala, Sweden

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

  • Multi-Organ Transplant, University Health Network, Toronto, ON, Canada

  • University Health Network, University of Toronto, Division of General Surgery, Toronto, Canada

  • Henry Ford Hospital, Department of Surgery, Detroit, United States

  • London School of Hygiene & Tropical Medicine, Department of Health Services Research and Policy, London, United Kingdom

Locations

  • Australia

  • United Kingdom

  • Canada

  • Netherlands

  • United States

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Liver cancer

  • Nonalcoholic steatohepatitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final